These answers draw in part from “Updates & Private Equity in ABA w/ Rick Kubina (BACB, BCBA, RBT)” (The Daily BA), and extend it with peer-reviewed research from our library of 27,900+ ABA research articles. Clinical framing, BACB ethics code references, and cross-links below are synthesized by Behaviorist Book Club.
View the original presentation →Private equity firms are investment companies that acquire businesses with the goal of increasing their value over a defined period, typically three to seven years, before selling them at a profit. ABA attracted private equity interest because of several factors: the growing prevalence of autism diagnoses created increasing demand for services, state insurance mandates created reliable revenue streams, and the fragmented market of small and mid-sized providers created consolidation opportunities. Private equity firms acquire ABA companies, invest in growth and operational improvement, and aim to sell the resulting larger organization at a higher valuation. This model has brought significant capital to the field but has also raised concerns about the effect of financial pressures on clinical quality.
The effects are variable and depend on how the specific private equity firm and the organization's management balance financial and clinical priorities. Potential negative effects include pressure to increase caseload sizes, reduce supervision hours, maximize billable hours, and minimize costs in ways that compromise clinical quality. Potential positive effects include investment in technology, training, and infrastructure that smaller providers cannot afford, and the operational efficiencies that come with scale. The critical variable is whether the organization's leadership maintains clinical quality as a genuine priority alongside financial performance. Practitioners should evaluate their specific organization's practices rather than assuming all private equity-backed organizations operate the same way.
Key factors to evaluate include the organization's ownership structure and financial model, caseload sizes and supervision ratios, how the organization handles conflicts between financial targets and clinical needs, staff turnover rates (high turnover may signal poor working conditions), whether clinical decisions are made by clinicians or overridden by management, the availability and quality of supervision and mentoring, the organization's reputation among families and practitioners, and whether there are mechanisms for raising ethical concerns without retaliation. Ask specific questions during the interview process about these factors, and talk to current employees if possible. Trust your professional judgment about whether the organization's culture supports quality practice.
The BACB regularly updates certification requirements, ethical standards, and supervisory guidelines. Practitioners should monitor BACB communications for changes to continuing education requirements, updates to the Ethics Code or its interpretation, changes to supervision standards and ratios, new certification pathways or credential modifications, enforcement actions that provide guidance on ethical expectations, and regulatory engagement efforts that affect state-level practice requirements. Specific updates change over time, so the most reliable approach is to regularly visit the BACB website, subscribe to BACB newsletters, and participate in professional communities that discuss BACB developments.
Workforce dynamics have direct and significant effects on clinical quality. High behavior technician turnover disrupts treatment continuity, as clients must repeatedly adjust to new practitioners. BCBA shortages lead to excessive caseloads, reduced supervision quality, and the assignment of practitioners to cases outside their areas of competence. Wage pressures, particularly for behavior technicians, affect the quality of candidates entering the workforce and the retention of experienced staff. When organizations cannot recruit and retain qualified staff, clinical quality inevitably suffers through understaffing, increased burden on remaining staff, and disruption of established therapeutic relationships. These workforce challenges require systemic solutions including improved compensation, better working conditions, and expanded training pipelines.
Your ethical obligations are clear even when the path forward is difficult. Code 2.01 requires providing effective treatment regardless of organizational pressures. Code 2.16 requires identifying conditions necessary for effective programming and communicating concerns to relevant parties. Start by documenting specific instances where clinical quality is being compromised by financial pressures. Raise your concerns through available channels, beginning with your direct supervisor and escalating as needed. If internal channels are ineffective, consider consulting with the BACB or relevant licensing boards. Throughout this process, protect your clients by maintaining your own ethical standards even if organizational norms have drifted. Recognize that you may ultimately need to decide whether you can continue practicing ethically within the organization.
Insurance regulation has profound effects on ABA service delivery. State mandates requiring coverage of ABA services created the funding foundation for the field's growth, but insurance companies' utilization management practices significantly shape how services are delivered. Authorization limits on the number of treatment hours, requirements for frequent reauthorization, specific documentation requirements, and medical necessity review processes all influence clinical decision-making. Practitioners must navigate these systems while maintaining their ethical obligation to recommend treatment based on clinical need rather than insurance parameters. When insurance limitations conflict with clinical recommendations, practitioners should document the clinical rationale and advocate for appropriate coverage.
Individual behavior analysts have more influence than they may realize. Career choices matter: choosing to work for organizations that prioritize clinical quality sends a market signal about what practitioners value. Advocacy within organizations matters: raising concerns about working conditions, caseload sizes, and supervision quality can influence management decisions, especially when multiple practitioners speak up. Professional advocacy matters: participating in professional organizations, engaging with regulatory processes, and supporting policy initiatives that promote quality and accountability contribute to systemic change. Clinical excellence matters: demonstrating through your own practice that ethical, high-quality ABA produces measurable outcomes helps build the case for clinical quality as a business strategy, not just an ethical obligation.
Preparation involves several dimensions. Professionally, invest in developing specialized expertise that makes you valuable regardless of organizational changes. Build a strong professional network that provides career opportunities and professional support. Maintain your own ethical standards and document your practice carefully. Financially, understand the business side of ABA well enough to evaluate employers and negotiate working conditions. Strategically, stay informed about industry trends so you can anticipate changes rather than merely reacting to them. And collectively, engage with professional organizations and advocacy efforts that work to protect the conditions necessary for quality practice as the industry evolves.
Yes, it is possible, and some private equity-backed organizations do deliver quality services. The ownership structure alone does not determine clinical quality. What matters is how the organization's leadership balances financial and clinical priorities, the specific policies and practices in place to protect clinical quality, the culture around ethical practice and clinical decision-making, and the working conditions provided to clinicians and behavior technicians. Behavior analysts should evaluate each organization based on its actual practices rather than making blanket assumptions based on ownership structure. At the same time, practitioners should be aware that the financial incentive structures of private equity create pressures that require active management and vigilance to prevent erosion of clinical quality.
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Ready to go deeper? This course covers this topic with structured learning objectives and CEU credit.
Updates & Private Equity in ABA w/ Rick Kubina (BACB, BCBA, RBT) — The Daily BA · 1 BACB Ethics CEUs · $24.99
Take This Course →We extended these answers with research from our library — dig into the peer-reviewed studies behind the topic, in plain-English summaries written for BCBAs.
279 research articles with practitioner takeaways
252 research articles with practitioner takeaways
239 research articles with practitioner takeaways
1 BACB Ethics CEUs · $24.99 · The Daily BA
Research-backed educational guide with practice recommendations
Side-by-side comparison with clinical decision framework
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.